A resolution to recognize October 2025 as Uterine Fibroids Awareness Month.
Take action
Record your position on this measure.
Create an account to record your position, submit testimony, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed Senate
- Passed House
- To Governor
- Became Law
Overview
This resolution aims to recognize October 2025 as Uterine Fibroids Awareness Month. It highlights the prevalence of uterine fibroids, a common non-cancerous growth in the uterus that can cause significant health issues and impact a woman’s quality of life. The resolution also acknowledges disparities in diagnosis and treatment rates, particularly among women of color, and emphasizes the need for increased awareness and research into this condition.
Key provisions
- Designates October 2025 as Uterine Fibroids Awareness Month.
- Recognizes the potential health impacts of uterine fibroids, including pain, reproductive dysfunction, and infertility.
- Acknowledges disparities in fibroid diagnosis and treatment rates among women of color.
- Urges greater research and data collection related to uterine fibroids.
- Highlights the economic burden associated with uterine fibroids, estimated at $42.2 billion annually.
- Mentions various treatment options, including medicinal and surgical approaches.
- Notes the increasing prevalence of uterine fibroids in the U.S.
- Calls for improved prevention, screening, diagnosis, and treatment methods.
Who is affected
- Women
- Women of color (specifically Black and Hispanic women)
- Healthcare providers
Notable changes
Bill text
Read the latest version inline or switch to a previous version.
Document of record
- Version
- Senate Enrolled Resolution
- Published
- Not published in the source record
This version is published only as a document. Open the viewer to read it here, or download the file.
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours